Pacific Biosciences
(PACB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2008 | |
| Assets | |
| Current Assets | |
| Cash & Cash Equivalents | 78,462 |
| Marketable Securities | 27,589 |
| Other current assets | 875 |
| TOTAL | $106,926 |
| Non-Current Assets | |
| PPE Net | 12,093 |
| TOTAL | $12,093 |
| Total Assets | $113,107 |
| Liabilities | |
| Current Liabilities | |
| TOTAL | $4,702 |
| Non-Current Liabilities | |
| Long Term Debt | 567 |
| Other Non-Current Liabilities | 142 |
| TOTAL | $709 |
| Total Liabilities | $5,411 |
| Shareholders' Equity | |
| Retained earnings | -104,298 |
| Other shareholders' equity | 211,994 |
| TOTAL | $107,696 |
| Total Liabilities And Equity | $113,107 |